[Severe sepsis--new therapeutic options].
Walmrath
D
D
Medizinische Klinik und Poliklinik II, Zentrum für Innere Medizin, Universitätsklinikum Giessen, Justus-Liebig-Universität, Klinikstrasse 36, 35392 Giessen. Hans-Dieter.Walmrath@innere.med.uni-giessen.de
Grimminger
F
F
Seeger
W
W
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D006801:Humans; D011175:Positive-Pressure Respiration / Q000379:methods; D011486:Protein C / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012128:Respiratory Distress Syndrome / Q000628:therapy; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D012720:Severity of Illness Index; D012772:Shock, Septic / Q000628:therapy; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis* / Q000628:therapy
D000276:Adjuvants, Immunologic; D011486:Protein C